SCHEMBL23075319

SCHEMBL23075319

CNC1COc2ccc(C#CC(C)(C)O)cc2N(C)C1=O

nearest known ligand 0.63

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 20/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23085752 0.91 RIPK1 (0.59) RIPK1
SCHEMBL25077587 0.89 RIPK1 (0.60) RIPK1
SCHEMBL23075456 0.89 RIPK1 (0.61) RIPK1
SCHEMBL26381841 0.85 RIPK1 (0.56) RIPK1
SCHEMBL21531284 0.85 RIPK1 (0.63) RIPK1
SCHEMBL21531281 0.85 RIPK1 (0.63) RIPK1
SCHEMBL21531314 0.84 RIPK1 (0.55) RIPK1
SCHEMBL21531311 0.84 RIPK1 (0.55) RIPK1
SCHEMBL30635182 0.81 RIPK1 (0.82) RIPK1
SCHEMBL24076710 0.81 RIPK1 (0.64) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021046447-A1 HETEROCYCLIC RIP1 KINASE INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2021-03-11 — — WO disclosed
Send feedback